Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T09:48:33.431Z Has data issue: false hasContentIssue false
  • English
  • Français

The Decrease in Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infections and Savings From Glycopeptide Use

Published online by Cambridge University Press:  21 June 2016

Diler Coşkun  and
Jale Aytaç
Diler Coşkun*
Affiliation:
Department of Microbiology, Medical Faculty, Istanbul Science University, Caglayan, Istanbul, Turkey
Jale Aytaç
Affiliation:
Department of Infectious Diseases and Clinical Microbiology, Florence Nightingale Hospital, Caglayan, Istanbul, Turkey
*
Sedef cad. Ata 2-2 Blok, D: 83, Atasehir-Kadikoy, 34 758 Istanbul, Turkey, ([email protected])
Get access Rights & Permissions [Opens in a new window]

Extract

We evaluated changes in the rate of healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) infections and healthcare-associated S. aureus infections after implementation of infection control precautions and the effect of this on glycopeptide use and expenditures for glycopeptides in a private medical center in Turkey in the years 2000-2005. A striking decrease was obtained in the number of MRSA infections, and the expenditure for glycopeptide use also decreased

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 10 , October 2006 , pp. 1131 - 1132
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Rubinovitch, B, Pittet, D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 2001; 47:9–18.Google Scholar
2. Abramson, MA, Sexton, DJ. Healthcare-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20:408–411.Google Scholar
3. Coskun, D, Aytac, J, Deveci, S, Sonmez, E. Evaluation of surgical-site infections following cardiovascular surgery. Infect Control Hosp Epidemiol 2004;25:451–453.Google Scholar
4. Garner, JS, Gaynes, RP, Martone, WJ, Jarvis, WR, Emori, TG. Centers for Disease Control and Prevention definitions for nosocomial infections, 1998. Am J Infect Control 1988; 16:128–140.Google Scholar
5. Horan, TG, Gaynes, RP, Martone, WJ, Jarvis, WR, Emori, TG. CDC definitions of surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20:271–274.Google Scholar
6. Jacqua-Stewart, MJ, Tjaden, J, Humpreys, DW, et al. Reduction in methicillin-resistant Staphylococcus aureus infection rate in a nursing home by aggressive containment strategies. S D J Med 1999; 52:241–247.Google Scholar
7. Kotilainen, P, Routamaa, M, Peltonen, R, et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 2001; 161:859–863.CrossRefGoogle Scholar